ArticleMolecular psychiatry2026
Decoding depression: stress-derived formaldehyde initiates depressive symptoms in mouse and human.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
Abstract
Stress is a high-risk factor for major depressive disorder (MDD) with hippocampal damage and monoamine deficiency. Surprisingly, the administration of gaseous or aqueous formaldehyde (FA) causes depressive symptoms in both animals and humans, though whether endogenous FA induces depression is unclear. Here, we report that stress-derived FA promotes depression onset. In this study, endogenous FA concentrations in mice and human induced by acute or chronic stress were quantified by a FA-sensitive fluorescence probe. Acute infusion and chronic FA injection were used to mimic depressive behaviors in mice under chronic unpredictable mild stress (CUMS). Patch clamp recorded FA-inhibited hippocampal CA1 discharges, while mass spectrometry and spectrophotometry examined FA-inactivated monoamine. The software of magnetic resonance imaging (MRI) was used to quantify hippocampal CA1 atrophy in adolescents with MDD. Biochemical tests were applied for evaluating the link between FA levels and depression severity in MDD patients. Various bioinformatics methods were used to explore FA's connection to depression-related pathways. Metabolomics data from MENDA were used to identify FA accumulation and monoamine deficiency in depression models and MDD patients. Our results showed that in cellular and mouse models, glutamic acid and both acute and chronic stress triggered FA production in hippocampal CA1 neurons. Excessive FA indued depressive behaviors due to FA buildup and decreased serotonin, dopamine, and melatonin levels in the extracellular space. Especially, excessive FA deactivated these monoamines, damaged hippocampal CA1 structure, and reduced neuroexcitability. Remarkably, adolescent MDD patients showed hippocampal CA1 atrophy and monoamine deficiencies, with blood FA levels predicting depression severity. These findings suggest that stress-derived FA serves as a critical trigger of depression by inactivating monoamines and impairing hippocampal CA1.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.